MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11102-020-01097-1

Медицинская библиотека · Pituitary · 2020

Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing's disease.

Fontaine-Sylvestre Cédric, Létourneau-Guillon Laurent, Moumdjian Robert A, Berthelet France, Lacroix André

Клинический случайСтатьяПеревод в очереди

Аннотация

PURPOSE: Corticotroph tumor progression (CTP) or Nelson's syndrome (NS) can occur in patients with Cushing's disease (CD) following bilateral adrenalectomy. It has rarely been observed in patients treated with long-term medical therapy for persistent CD. Osilodrostat (LCI699) is a new steroidogenesis inhibitor of 11β-hydroxylase (CYP11β1) that induced remission of hypercortisolism in 86% of patients with refractory CD in the randomized placebo-controlled trial LINC-3 (NCT02180217).

METHODS

A 40-year-old woman with persistent CD following transsphenoidal surgery was treated with osilodrostat in the LINC-3 trial and was followed with regular hormonal assessments and imaging of residual corticotroph tumor.

RESULTS

Under oral therapy with osilodrostat 10 mg twice daily, urinary free cortisol (UFC) normalized and clinical signs of CD regressed during therapy. However after 4 years of treatment, ACTH levels increased from 73 to 500 pmol/L and corticotroph tumor size increased rapidly from 3 to 14 mm, while UFCs remained well controlled. Surgical resection of an atypical tumor with weak ACTH expression and increased proliferative index (Ki-67 ≥ 8%) resulted in current remission but will require close follow-up.

CONCLUSION

This case highlights the importance of monitoring ACTH and corticotroph tumor size in patients with persistent CD, either under effective treatment with steroidogenesis inhibitors or after bilateral adrenalectomy.

Для цитирования: Fontaine-Sylvestre Cédric, Létourneau-Guillon Laurent, Moumdjian Robert A, Berthelet France, Lacroix André. Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing's disease.. Pituitary. 2020. DOI: 10.1007/s11102-020-01097-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.